Antiviral Drugs Market Analysis by Drug Class (Reverse Transcriptase Inhibitors, DNA Polymerase Inhibitors, Neuraminidase Inhibitors, Protease Inhibitors), by Type (Generic, Branded), by Application (Hepatitis, HIV, Influenza, Herpes), and by Region - Forecast to 2029

Request Sample Page

The global antiviral drugs market size is estimated to be USD 56.81 billion in 2021 and is expected to witness a CAGR of 4.51% during the forecast period. Rising incidence of viral infections such as hepatitis, influenza, corona virus, and Human Immunodeficiency Virus (HIV) is a key driver for global antiviral drugs market growth. Moreover, growth in clinical trials, rising R&D investment, government initiatives for availability of advanced drugs with lesser adverse effects, and changing regulatory measures are other drivers expected to propel the market growth. However, stringent regulatory regulations and lack of skilled research professionals are expected to restrain global growth.

Global Antiviral Drugs Market Size (USD Billion), 2021-2029

Source: Erevna Healthcare

By Drug Class

Based on drug class, the market is segmented into reverse transcriptase inhibitors, DNA polymerase inhibitors, neuraminidase inhibitors, protease inhibitors, and others. In 2021, the reverse transcriptase inhibitors segment accounted for the maximum revenue share due to their ability to reduce the rate at which a viral infection spreads and increasing R&D initiatives by pharmaceutical companies. This segment is also expected to grow at the fastest CAGR during the forecast period. DNA polymerase inhibitors segment is expected to witness significant growth during the forecast period.

By Type

Based on type, the market is categorized into generics and branded. In 2021, the branded segment accounted for the maximum revenue share as consumers perceive branded medicines to be of higher quality, worldwide. Generic segment is anticipated to grow at fastest CAGR during the forecast period, due to the increasing consumer awareness about the benefits of generic medicine and government initiatives.

By Application

Based on application, the market is categorized into hepatitis, HIV, influenza, herpes, and others. Hepatitis segment accounted for the highest revenue in 2021 and is projected to maintain its dominance over the forecast period. Hepatitis is of three types, i.e., A, B, and C and there are many antiviral drugs available to treat each type of hepatitis. The market is driven by increasing prevalence and incidence of varied types of hepatitis. HIV is the fastest growing segment for antiviral drugs due to the presence of a large patient base worldwide.

Regional Insights

In 2021, North America accounted for the highest revenue share in the global market and is expected to maintain its dominance during the forecast period. This is attributed to the presence of advanced healthcare infrastructure & large number of pharmaceutical and biotechnology firms and increase in awareness about the importance of antiviral drugs by the government. In the U.S., cutting-edge medical research infrastructure coupled with extensive drug clinical trials are fuelling the growth of antiviral drugs.

Asia Pacific is expected to grow at the fastest CAGR over the forecast period owing to the rising prevalence of antiviral diseases, improving healthcare sector, and rising research & development activities in this region.

Competitor Insights

Some of the major companies in the antiviral drugs market are Bristol Myers Squibb (U.S.), Gilead Sciences, Inc. (U.S.), Cipla Limited (U.S.), F. Hoffmann-La Roche AG, (Switzerland), Aurobindo Pharma Limited (India), AbbVie Inc. (U.S.), Dr. Reddy’s Laboratories (India), Merck & Co., Inc. (U.S.), Johnson & Johnson (U.S.), and GlaxoSmithKline plc (U.K.). The leading players have adopted strategic collaborations, mergers & acquisitions, and novel product development approaches to capture the market share.

This exhaustive research report focuses on market size and forecast at global, segmental, regional and country-level along with key market trends and dynamics from 2021 to 2029. The antiviral drugs market report is categorized into the following segments and subsegments:

Antiviral Drugs Market, By Drug Class (Revenue, 2021-2029, USD Billion)

  • Reverse Transcriptase Inhibitors (RTI)
  • DNA Polymerase Inhibitors (DPI)
  • Neuraminidase Inhibitors (NI)
  • Protease Inhibitors (PI)
  • Others

Antiviral Drugs Market, By Types (Revenue, 2021-2029, USD Billion)

  • Generics
  • Branded

Antiviral Drugs Market, By Application (Revenue, 2021-2029, USD Billion)

  • Hepatitis
  • HIV
  • Influenza
  • Herpes
  • Others

Antiviral Drugs Market, By Region (Revenue, 2021-2029, USD Billion)

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Spain
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of LATAM
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Scope of Antiviral Drugs Market Report:

Key Parameters Details
Base Year
  • 2021
Forecast Period
  • 2022-2029
Study Coverage
  • Global and regional market size and revenue forecast
  • Segment market size and revenue forecast at global, regional, and country level
  • Competitive landscape (company share analysis, company profiles, recent development, competitive map analysis)
  • Conclusion and recommendations
Qualitative Analysis
  • Market drivers
  • Market restraints
  • Market opportunities
  • Recent market trends
  • Market challenges
  • Porter’s Five Forces analysis
  • PEST analysis
  • Value-chain analysis
  • COVID-19 impact analysis
Regional Market Scope
  • North America (U.S. and Canada)
  • Europe (Germany, France, UK, Spain, Italy, Russia, Rest of Europe)
  • Asia Pacific (China, Japan, India, Australia, South Korea, Rest of APAC)
  • Latin America (Brazil, Mexico, Argentina, Rest of LATAM)
  • MEA (South Africa, GCC, Rest of MEA)
Company Profiles
  • Exhaustive profiles of top 10 players
  • 50+ other major players listing
15% Free Customization Available
  • You can customize the study scope to meet your exact requirement. Click here for more details

Table of Contents: Antiviral Drugs Market 2021-2029

  1. Research Methodology
    1. Study Objectives
    2. Study Scope
    3. Research Assumptions
    4. Research Framework
      1. Research Models
        1. Bottom-up Approach
        2. Top-down Approach
        3. Data Triangulation
      2. Data Procurement
        1. Internal Database
        2. Secondary Research
        3. Purchased Database
        4. Primary Research
      3. Data Analysis
        1. Data Validation
        2. Market Size Estimation
        3. Market Forecast Model
      4. Quality Assessment
  1. Introduction: Antiviral Drugs
  2. Executive Summary
    1. Global Market Scenario
    2. Segment Market Scenario
    3. Geographic Market Scenario
    4. COVID-19 Impact
    5. Competitive Landscape
  3. Market Dynamics
    1. Market Drivers
      1. Driver 1
      2. Driver 2
      3. Driver 3
      4. Driver 4
      5. Driver 5
    2. Market Restraint
      1. Restraint 1
      2. Restraint 2
      3. Restraint 3
      4. Restraint 4
    3. Market Opportunities
      1. Opportunity 1
      2. Opportunity 2
      3. Opportunity 3
      4. Opportunity 4
    4. Market Trends
      1. Trend 1
      2. Trend 2
      3. Trend 3
      4. Trend 4
    5. Market Challenges
      1. Challenge 1
      2. Challenge 2
      3. Challenge 3
      4. Challenge 4
  1. Market Environment Analysis
    1. Porter’s 5 Forces Analysis
    2. PESTEL Analysis
    3. Value Chain Analysis
    4. SWOT Analysis
    5. Benchmark
  2. COVID-19 Impact Analysis: Antiviral Drugs Market
    1. COVID-19: Overview
    2. COVID-19 Impact on the Global Market
    3. COVID-19 Impact on the Regional Markets
  3. Market Analysis by Drug class
    1. Protease inhibitors
      1. Protease inhibitors Market Forecast, 2021-2029 (USD Million)
    2. DNA polymerase

7.2.1.DNA polymerase Market Forecast, 2021-2029 (USD Million)

  1. Reverse transcriptase inhibitors
    1. Reverse transcriptase inhibitors Market Forecast, 2021-2029 (USD Million)
  2. Neuraminidase inhibitors
    1. Neuraminidase inhibitors Market Forecast, 2021-2029 (USD Million)
  3. Other
    1. Other Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Application
    1. Hepatitis
      1. Hepatitis Market Forecast, 2021-2029 (USD Million)
    2. Herpes
      1. Herpes Market Forecast, 2021-2029 (USD Million)
    3. HIV
      1. HIV Market Forecast, 2021-2029 (USD Million)
    4. Influenza
      1. Influenza Market Forecast, 2021-2029 (USD Million)
    5. Others
      1. Others Market Forecast, 2021-2029 (USD Million)
  1. Market Analysis by Type
    1. Generics
      1. Generics Market Forecast, 2021-2029 (USD Million)
    2. Branded
      1. Branded Market Forecast, 2021-2029 (USD Million)
  1. Regional Market Analysis
    1. Regional Market Trends
    2. Regional Market: Comparative Analysis
  2. North America Antiviral DrugsMarket
    1. North America Antiviral DrugsMarket
      1. North America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by Type, 2021-2029 (USD Million)
      2. S. Antiviral DrugsMarket
        1. S. Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Canada Antiviral DrugsMarket
          1. Canada Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by Type, 2021-2029 (USD Million)
  1. Europe Antiviral Drugs Market
    1. Europe Antiviral Drugs Market
      1. Europe Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by Type, 2021-2029 (USD Million)
      2. Germany Antiviral Drugs Market
        1. Germany Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. UK Antiviral Drugs Market
          1. UK Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. France Antiviral Drugs Market
            1. France Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Spain Antiviral Drugs Market
              1. Spain Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Italy Antiviral Drugs Market
                1. Italy Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                  3. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Rest of Europe Antiviral Drugs Market
                  1. Rest of Europe Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    3. Market Size and Forecast by Type, 2021-2029 (USD Million)
  1. Asia Pacific Antiviral DrugsMarket
    1. Asia Pacific Antiviral Drugs Market
      1. Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by Type, 2021-2029 (USD Million)
      2. Japan Antiviral Drugs Market
        1. Japan Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. China Antiviral Drugs Market
          1. China Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. India Antiviral Drugs Market
            1. India Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
            2. South Korea Antiviral Drugs Market
              1. South Korea Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by Type, 2021-2029 (USD Million)
              2. Australia Antiviral Drugs Market
                1. Australia Market Size and Forecast, 2021-2029 (USD Million)
                  1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                  2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                  3. Market Size and Forecast by Type, 2021-2029 (USD Million)
                2. Rest of Asia Pacific Antiviral Drugs Market
                  1. Rest of Asia Pacific Market Size and Forecast, 2021-2029 (USD Million)
                    1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                    2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                    3. Market Size and Forecast by Type, 2021-2029 (USD Million)
  1. Latin America Antiviral DrugsMarket
    1. Latin America Antiviral Drugs Market
      1. Latin America Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by Type, 2021-2029 (USD Million)
      2. Brazil Antiviral Drugs Market
        1. Brazil Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. Mexico Antiviral Drugs Market
          1. Mexico Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Argentina Antiviral Drugs Market
            1. Argentina Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by Type, 2021-2029 (USD Million)
            2. Rest of Latin America Antiviral Drugs Market
              1. Rest of Latin America Market Size and Forecast, 2021-2029 (USD Million)
                1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
                2. Market Size and Forecast by Application, 2021-2029 (USD Million)
                3. Market Size and Forecast by Type, 2021-2029 (USD Million)
  1. MEA Antiviral DrugsMarket
    1. MEA Antiviral Drugs Market
      1. MEA Market Size and Forecast, 2021-2029 (USD Million)
        1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
        2. Market Size and Forecast by Application, 2021-2029 (USD Million)
        3. Market Size and Forecast by Type, 2021-2029 (USD Million)
      2. GCC Antiviral Drugs Market
        1. GCC Market Size and Forecast, 2021-2029 (USD Million)
          1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
          2. Market Size and Forecast by Application, 2021-2029 (USD Million)
          3. Market Size and Forecast by Type, 2021-2029 (USD Million)
        2. South Africa Antiviral Drugs Market
          1. South Africa Market Size and Forecast, 2021-2029 (USD Million)
            1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
            2. Market Size and Forecast by Application, 2021-2029 (USD Million)
            3. Market Size and Forecast by Type, 2021-2029 (USD Million)
          2. Rest of MEA Antiviral Drugs Market
            1. Rest of MEA Market Size and Forecast, 2021-2029 (USD Million)
              1. Market Size and Forecast by Drug class, 2021-2029 (USD Million)
              2. Market Size and Forecast by Application, 2021-2029 (USD Million)
              3. Market Size and Forecast by Type, 2021-2029 (USD Million)
  1. Competitor Analysis
    1. Market Share Analysis, 2020 & 2031
    2. Competitive Mapping
    3. Key Players Market Place Analysis
    4. Major Recent Developments
  2. Company Profiles
    1. Thermo Fisher Scientific Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    2. Merck KGaA (Germany)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    3. Avantor, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    4. ThermoGenesis Holdings, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    5. Bio-Techne Corporation (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    6. BioLife Solutions, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    7. Exact Sciences Corporation (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    8. Worthington Industries, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    9. Chart Industries, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    10. So-Low Environmental Equipment Co., Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    11. Shanghai Genext Medical Technology Co. Ltd (China)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    12. PHC Holdings Corporation (Japan)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    13. Helmer Scientific, Inc. (US)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    14. Arctiko (Denmark)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    15. AMS Biotechnology (England)
      1. Company Snapshot
      2. Company Overview
      3. Financials
      4. Product Benchmarking
      5. Recent Developments
    16. Others Prominent Players
  3. Conclusion & Recommendations

Select License Type

Buy Now

7 Reasons to Choose EHMR Reports

  • Customer’s Satisfaction

    First and foremost client’s satisfaction, which is very important for Erevna Healthcare and we are committed towards it

  • Client Report

    Customised reports

    Expert in healthcare domain and in depth insights on the report. Erevna Healthcare also customise reports as per the client’s requirement

  • Analyst Support

    Experienced team of analysts with strong background in Pharma, Life Sciences and Biotechnology

  • Assured Quality

    Each report passes through three tiers of quality check

  • Stick to the timeline

    Stick to the timeline

    Erevna Healthcare analysts stick to the timeline

  • Quick delivery

    Quick delivery of reports as per client’s request in three different forms i.e. pdf, ppt and word

  • 24x7 Supprt

    24*7 Support

    24*7 Support post delivery/dispatch of all the reports

Trending Reports